According to authorities in China, a drug used in Japan to treat new strains of influenza has appeared to be effective in coronavirus patients.
An official at China’s science and technology ministry, said favipiravir, developed by a subsidiary of Fujifilm, had produced encouraging outcomes in clinical trials in Wuhan and Shenzhen involving 340 patients.
Patients who were given the medicine turned negative for the virus after an average of four days after becoming positive, compared with an average of 11 days for those who were not treated with the drug.
In addition, X-rays confirmed improvements in lung condition in about 91% of the patients who were treated with favipiravir, compared to 62% or those without the drug.
A bill on purchasing power will be introduced by the French government shortly according to a government spokesperson...
Read More
As part of its ecological restoration program, the Department of the Environment here in the Principality had installed five "Tide-pool"-type riprap r...
Read More
Bison Futé has classified traffic throughout France as red this Wednesday and Thursday, when many will be leaving for the only long weekend in May....
Read More
The father of British Prime Minister Boris Johnson Stanley, says he is “absolutely delighted” having received confirmation that he has acquired French...
Read More
The first Council of Ministers meeting is taking place today Monday 23rd May,
Read More
